This is the fourth of a series of 4 white papers that represent expert consensus documents developed by the Society of Computed Body Tomography and Magnetic Resonance through its task force on dual-energy computed tomography. This article, part 4, discusses DECT for abdominal and pelvic applications and, at the end of each, will offer our consensus opinions on the current clinical utility of the application and opportunities for further research.
From the *Division of Cardiovascular Imaging, Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC; †Department of Radiology, University Hospital of Basel, Basel, Switzerland; ‡Department of Radiology, University of Alabama at Birmingham, Birmingham, AL; §Department of Radiology, Medical College of Wisconsin, Milwaukee, WI; ∥Department of Radiology, University of Michigan Hospitals, Ann Arbor, MI; ¶Department of Radiology, UT Southwestern Medical Center, Dallas, TX; #Division of Abdominal Imaging, Department of Radiology, Massachusetts General Hospital, Boston, MA; **Department of Radiology, University of Washington School of Medicine, Seattle, WA; ††Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, MO; ‡‡Department of Radiology, Mayo Clinic College of Medicine, Rochester, MN; and §§Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA.
Received for publication August 10, 2016; accepted August 12, 2016.
Correspondence to: Lincoln L. Berland, MD, Department of Radiology, University of Alabama at Birmingham, 619 S, 19th St, N454, Birmingham, AL 35249 (e-mail: email@example.com).
The authors state that this work has not received any funding.
The authors of this article declare relationships with the following companies: Astellas, Bayer, Bracco, GE Healthcare, Guerbet, Medrad, Nextrast, Inc, NIH, Nuance Communications, Inc, Oxford University Press, and Siemens Healthcare.